Koers Zalicus Inc Nasdaq
Aandelen
US98887C1053
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
2016 | Transcript : EPIRUS Biopharmaceuticals, Inc., Q4 2015 Earnings Call, Mar 15, 2016 | |
2015 | Transcript : EPIRUS Biopharmaceuticals, Inc., Q3 2015 Earnings Call, Nov 16, 2015 |
Omzet 2014 | 0 0 | Omzet 2015 | 0,7 0,65 | Marktkapitalisatie | 75,33 mln. 69,95 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2014 | -41 mln. -38,07 mln. | Nettowinst (verlies) 2015 | -52 mln. -48,28 mln. | EV/omzet 2014 | 14.770.294.750 x |
Nettoliquiditeiten 2014 | 14,18 mln. 13,17 mln. | Nettoliquiditeiten 2015 | 16,68 mln. 15,49 mln. | EV/omzet 2015 | 83.658.631 x |
K/w-verhouding 2014 |
-0,83
x | K/w-verhouding 2015 |
-1,35
x | Werknemers | - |
Dividendrendement 2014 * |
-
| Dividendrendement 2015 |
-
| Vrij verhandelbaar | 100% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+17,96% | 44,96 mld. | |
+48,77% | 41,85 mld. | |
+1,17% | 42,65 mld. | |
-4,27% | 29,04 mld. | |
+11,42% | 26,08 mld. | |
-21,39% | 19,03 mld. | |
+4,86% | 12,75 mld. | |
+27,29% | 12,06 mld. | |
-3,50% | 11,75 mld. |
- Beurs
- Aandelen
- Koers EPRSQ
- Koers